← Founder Notes
Archive

The first ai-designed drug just reached the last trial gate. insilico's rentosertib, with both…

Yethikrishna ROriginal on Threads

the first ai-designed drug just reached the last trial gate. insilico's rentosertib, with both target discovery and molecular design done by generative ai, began phase three dosing for idiopathic pulmonary fibrosis on september 10, while abbvie paired with iambic on september 21 to speed discovery further.

phase three is where most drugs die, so this one is now the test.

Provenance

The note above is reproduced unedited from the original post, first published on Threads on 24 September 2026 at 17:04 IST.

View the original post
Embed this note
<iframe src="https://founder.myndlabs.tech/notes/embed/the-first-ai-designed-drug-just-reached-the-DdqyhqIiGBO" width="480" height="420" style="border:0;max-width:100%" loading="lazy" title="The first ai-designed drug just reached the last trial gate. insilico's rentosertib, with both…"></iframe>

More notes